Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Avstera Therapeutics has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in October 2023.
Avstera Therapeutics is headquartered in Philadelphia, United States.
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Avstera Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avstera Therapeutics — Funding & Investors." VCBacked, October 2, 2023, https://www.vcbacked.co/company/avstera-therapeutics. Accessed August 1, 2026.
VCBacked. (2023). Avstera Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/avstera-therapeutics
{{cite web |title=Avstera Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/avstera-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated